As the United States accelerates the search for a coronavirus vaccine, tensions have erupted between government scientists and Moderna Inc, one of the leading developers, Reuters has learned.
FILE PHOTO: A sign marks the headquarters of Moderna Inc, which is developing a vaccine against the coronavirus, in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyder/File Photo
Moderna denied any missteps on its part but acknowledged “differences of opinion” with experts involved in the unprecedented effort to deliver on the Trump administration’s pledge to find a vaccine within months. It typically takes about a decade to develop a vaccine - and many efforts fail to produce one at all. Moderna said it has an experienced team that includes people who have run multiple large-scale trials.
Stephen Thomas, a vaccine developer who is chief of infectious diseases at SUNY Upstate Medical University, said vaccine development can spark such disagreements even without the pressures of an out-of-control pandemic. The NIH had hoped to launch Moderna’s large-scale trial by July 10 but the disputes with the company caused the delay, the sources said. Medical news site STAT first reported the trial delay on Thursday.
Moderna disputed that it withheld information, calling the complaint a misunderstanding about the company’s presentation at the meeting, which was not as detailed as others. HHS awarded Moderna $483 million in April to accelerate vaccine development and manufacturing. The company says it is already gearing up to produce at least 100 million doses this year to ensure supply even before trials prove its vaccine safe and effective.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA leader Stephen Hahn stops short of Trump promises on vaccine timingA recent poll showed 27% of adults are unlikely to accept a free COVID-19 vaccine, FDA Commissioner Stephen Hahn tells martharaddatz 'It is concerning... [FDA] will do our job to assess the safety and the efficacy of a vaccine candidate.'
Weiterlesen »
FDA Commissioner Stephen Hahn won’t confirm Trump’s promises on vaccine timingFDA Commissioner Stephen Hahn stops short of backing Pres. Trump's timeline suggesting a COVID-19 vaccine could be available “long before the end of the year,' telling MarthaRaddatz, 'I can't predict when a vaccine will be available.'
Weiterlesen »
Fauci warns that COVID-19 vaccine protection may be ‘finite’Speaking at a live-streamed videoconference hosted by the National Institutes of Health, Dr. Anthony Fauci, White House coronavirus task force member and director of the National Institute of Allergy and Infectious Diseases, said it is difficult to tell how long a vaccine will work.
Weiterlesen »
Make a vaccine? I'm trying to teach my kids the alphabetIt's tough to do any useful work when you're stuck at home, struggling to home-school bickering kids, let alone when you're trying to produce a COVID-19 vaccine.
Weiterlesen »
Coronavirus Researchers Compete to Enroll Subjects for Vaccine TestsCompanies behind candidate Covid-19 vaccines are making an unprecedented push to recruit tens of thousands of healthy volunteers for final-phase testing, targeting states where infections are surging.
Weiterlesen »
Stocks in Europe rally on economic optimismEuropean stocks rose Monday, as signs of economic progress offset worries about growing coronavirus cases in the U.S. as well as India.
Weiterlesen »